Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Shinde, V; Bhikha, S; Hoosain, Z; Archary, M; Bhorat, Q; Fairlie, L; Lalloo, U; Masilela, MSL; Moodley, D; Hanley, S; Fouche, L; Louw, C; Tameris, M; Singh, N; Goga, A; Dheda, K; Grobbelaar, C; Kruger, G; Carrim-Ganey, N; Baillie, V; de Oliveira, T; Koen, AL; Lombaard, JJ; Mngqibisa, R; Bhorat, AE; Benade, G; Lalloo, N; Pitsi, A; Vollgraaff, PL; Luabeya, A; Esmail, A; Petrick, FG; Oommen-Jose, A; Foulkes, S; Ahmed, K; Thombrayil, A; Fries, L; Cloney-Clark, S; Zhu, M; Bennett, C; Albert, G; Faust, E; Plested, JS; Robertson, A; Neal, S; Cho, I; Glenn, GM; Dubovsky, F; Madhi, SA

Shinde, V (corresponding author), Novavax, 21 Firstfield Rd, Gaithersburg, MD 20878 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2021; 384 (20): 1899

Abstract

BACKGROUND The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants threatens progress toward control of the coronavirus......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索